Wiley Rein Scores WilmerHale FDA Policy Guru
Czaban told Law360 that he chose Wiley Rein because it is “a very sophisticated Washington-oriented firm” with a well-established history of taking on “cutting-edge FDA related work.”
Czaban’s practice emphasizes the interrelated legal, regulatory and policy issues stemming from competitive pressures within the pharmaceutical industry.
In addition to product development and promotional...
Already a subscriber? Click here to login